Business Standard

Top headlines: SII buys 50% stake in vial maker; China tech stocks slump

Business Standard brings you the top headlines this evening

Serum Institute
Premium

Staffers cleaning the marquee board of Serum Institute | Photo: Abhishek Waghmare

BS Web Team
Serum Institute picks up 50% in glass vial maker Schott's Indian JV
 
Vaccine maker Serum Institute of India (SII) has picked up a 50 per cent stake in specialty glass company Schott AG’s Indian joint venture, Schott Kaisha, from the former co-owners Kairus Dadachanji and Shapoor Mistry for an undisclosed sum.

While the deal helps SII to have more control over its supply chain (glass vials are a critical component of vaccine packaging), it also helps the Kaisha group to focus on their other pharmaceutical ventures. Read more

India asks US court to

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in